Testing a new drug for uncontrolled high blood pressure
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your sitting blood pressure (top number) is between 140 and 179 mmHg.
- Your high blood pressure is not well controlled with your current medications, or it is resistant to treatment.
- You are willing to take the study drug and follow the study schedule.
- You agree to use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called QLS1410. It is given once to healthy volunteers and to people with mild high blood pressure to see how the body handles it and if it lowers blood pressure safely.
This trial tests a new modified-release drug, RTN-001, to see if it can help people whose blood pressure remains high despite taking at least two standard blood pressure medicines. You will take either RTN-001 or a placebo, and researchers will monitor your blood pressure closely.
This study tests the safety and how the body handles a new medicine (SAL0140) in healthy people. It helps doctors find the right dose and check for side effects.
This trial tests a new medicine called IBI3016 for people with mild to moderate high blood pressure. It aims to find the right dose to safely lower blood pressure without other blood pressure medications.
This trial tests whether personalized guidance from a pharmacist can help people with high blood pressure (hypertension) get their numbers under control. If you have mild to moderate high blood pressure and are not yet at your goal, this extra support may help you manage it better.
This early-stage study tests a new medication called IBI3016 to help lower blood pressure in people with mild to moderate hypertension who haven't recently taken blood pressure medications. The goal is to see if this drug is safe and effective.
Hear when a new Uncontrolled Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.